Screening of achillea santolina for anti-diabetic activity and its comparison with caralluma tuberculata.

Objectives: The study was designed to investigate the hypoglycaemic effect of Achillea santolina and its comparison with Caralluma tuberculata. Study Design: Experimental study. Setting: Khyber Medical University, Peshawar. Period: July 2017 to February 2018. Material & Methods: Crude extract and carbon tetrachloride (CCl4) extract of Achillea santolina were prepared and administered to normal and alloxan treated diabetic rabbits. These extracts were given in capsule form as well as in cooking oil and their effects on blood glucose levels were observed at 0, 2, 4, 6, 8, 12 and 24 hours of administration. The results were compared with Caralluma tuberculata. Results: The crude extract 200 mg/kg body weight of Achillea santolina showed marked reduction in mean blood glucose level at 2, 4, 8 and 12 hours with significant (p<0.001) difference when compared with Caralluma tuberculata. The metformin 500 mg/kg body weight was also given to compare its effects with the plant crude extracts, which was more or less intermediate between the crude extracts of Achillea santolina and Caralluma tuberculata. The diabetic rabbits were treated with 100 mg/kg body weight CCl4 fraction of Achillea in capsule form. Blood glucose levels dropped markedly at 2 hours and further more at 4 hours as observed with Caralluma. Upon comparison with metformin, Achillea found to lower blood glucose levels but quite late than metformin. The diabetic rabbits were also treated with 100 mg/kg body weight CCl4 fraction of Achillea santolina in cooking oil and Caralluma was found to cause higher reduction in blood glucose levels than Achillea. Conclusion: Both Achillea santolina and Caralluma tuberculata lowered the blood glucose levels but the later turned out to be more significant in developing hypoglycaemia, particularly when taken with cooking oil.

Download Full-text

Comparison of Caralluma tuberculata with Metformin for Anti-Diabetic Activity: An Animal Study

Journal of Islamabad Medical & Dental College ◽

10.35787/jimdc.v8i1.314 ◽

2019 ◽

Vol 8 (1) ◽

pp. 34-39

Author(s):

Muhammad Saleh Faisal ◽

Waqar Hayat ◽

Asad Inayat ◽

Muhammad Sohaib ◽

Waheed Iqbal

Keyword(s):

Body Weight ◽

Blood Glucose ◽

Carbon Tetrachloride ◽

Crude Extract ◽

Gum Tragacanth ◽

Glucose Levels ◽

Cooking Oil ◽

Blood Glucose Levels ◽

Group I ◽

Diabetic Rabbits

Background: Caralluma tuberculata, is a wild herb, which grows in the hills of Balochistan and has been known to have medicinal and nutritional properties since antiquity. This experimental research was designed to study the hypoglycemic properties of Caralluma tuberculata and to compare them with Metformin.Material and Methods: This was a laboratory-based animal experimental study. It was conducted in the Pharmacology laboratory of Khyber Medical University, Peshawar from February 2016 to August 2016. Two types of extracts of Caralluma tuberculata [crude extract and carbon tetrachloride (CCl4) extract] were prepared and administered to normal and alloxan treated diabetic rabbits. To study anti-diabetic activity, eighty-four rabbits were divided into two main groups. Group I (Normal/Non-Diabetic Rabbits; n= 21) and Group II (Diabetic/Alloxanized Rabbits; n=63). Each group was further divided into sub-groups (7 rabbits in each). Effect of Caralluma tuberculata, Metformin and 2% gum tragacanth on blood glucose levels were checked at 0, 2, 4, 6, 8, 12 and 24 hours of drug administration. The extracts were given in capsule form and in cooking oil. Data analysis was done using SPSS version 16. For calculation and comparison of the hypoglycemic effects at various doses and different time intervals, analysis of variance (ANOVA) and Tukey’s post hoc test were applied.Results: The crude extract, 200mg/kg body weight of Caralluma tuberculata showed significant decrease (p<0.001) in mean blood glucose levels from 2-hour till12 hours. Whereas, highly significant reduction of blood glucose was seen from 2 hours after treatment till 24 hours, when carbon tetrachloride (CCl4) fraction of Caralluma (100mg/kg body weight) in capsule form was administered. Metformin 500mg/kg body weight was given to compare its effects with plant crude extract and it was found that metformin appeared to be less effective in comparison with Caralluma tuberculata.Conclusion: Caralluma tuberculata lowered the blood glucose level and turned out to be more significant in developing hypoglycemia when taken with cooking oil. More work is essential to provide stronger evidence for the use of this natural agent in the management of Diabetes Mellites.

Download Full-text

The Effect of Extract/Fractions of Caralluma tuberculata on Blood Glucose Levels and Body Weight in Alloxan-Induced Diabetic Rabbits

Journal of Evidence-Based Complementary & Alternative Medicine ◽

10.1177/2156587214531019 ◽

2014 ◽

Vol 19 (3) ◽

pp. 195-199 ◽

Cited By ~ 1

Author(s):

Khushbakht Sultan ◽

Muhammad Zakir ◽

Haroon Khan ◽

Ihsaan Ullah Khan ◽

Ali Rehman ◽

...

Keyword(s):

Body Weight ◽

Blood Glucose ◽

Ethyl Acetate Fraction ◽

The Body ◽

Antidiabetic Activity ◽

Glucose Levels ◽

Blood Glucose Levels ◽

Cooked Food ◽

Diabetic Rabbits ◽

Positive Effect

Caralluma tuberculata is a cooked food item in Pakistan especially for diabetics. The current study was designed to explore the antidiabetic potential of extract/fractions of Caralluma tuberculata in alloxan-induced diabetic rabbits and its effect on body weight. The crude extract of the plant provoked 24% and 44% antidiabetic action at 25 and 50 mg/kg OP, respectively, after the 24th day of treatment, which was strongly supported by a positive effect on the body weight of animals. On fractionation, pretreatment of the ethyl acetate fraction demonstrated most dominant (25.17% and 34.83%) antidiabetic activity followed by n-hexane (19.33% and 32.76%) and aqueous fractions (16.44% and 22.36%) at 25 and 50 mg/kg OP, respectively, after the 24th day of treatment. The corresponding effect on blood glucose was also observed on body weight of diabetic rabbits. In sum, extract/fractions of the plant showed marked antidiabetic action and thus a provided scientific foundation to the use of the plant as an antidiabetic.

Download Full-text

Changes in Blood Glucose Levels and Body Weight in Patients Administered Sodium-Glucose Cotransporter 2 Inhibitors

Diabetes ◽

10.2337/db18-1167-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1167-P

Author(s):

HUN-SUNG KIM ◽

EUN YOUNG LEE ◽

KUN-HO YOON

Keyword(s):

Body Weight ◽

Blood Glucose ◽

Glucose Levels ◽

Blood Glucose Levels ◽

Sodium Glucose Cotransporter

Download Full-text

Evaluation of Glucose and Lipid Lowering Activity of Arganimide A in Normal and Streptozotocin-Induced Diabetic Rats

Endocrine Metabolic & Immune Disorders - Drug Targets ◽

10.2174/1871530318666181113124727 ◽

2019 ◽

Vol 19 (4) ◽

pp. 503-510 ◽

Cited By ~ 2

Author(s):

Mohamed Eddouks ◽

Farid Khallouki ◽

Robert W. Owen ◽

Morad Hebi ◽

Remy Burcelin

Keyword(s):

Body Weight ◽

Blood Glucose ◽

Oral Administration ◽

Lipid Profile ◽

Plasma Cholesterol ◽

Diabetic Rats ◽

Lipid Lowering ◽

Glucose Levels ◽

Blood Glucose Levels ◽

Lowering Activity

Aims: Arganimide A (4,4-dihydroxy-3,3-imino-di-benzoic acid) is a compound belonging to a family of aminophenolics found in fruit of Argania spinosa. The purpose of this study was to investigate the glucose and lipid lowering activity of Arganimide A (ARG A). Methods: The effect of a single dose and daily oral administration of Arganimide A (ARG A) on blood glucose levels and plasma lipid profile was tested in normal and streptozotocin (STZ) diabetic rats at a dose of 2 mg/kg body weight. Results: Single oral administration of ARG A reduced blood glucose levels from 26.50±0.61 mmol/L to 14.27±0.73 mmol/L (p<0.0001) six hours after administration in STZ diabetic rats. Furthermore, blood glucose levels were decreased from 5.35±0.30 mmol/L to 3.57±0.17 mmol/L (p<0.0001) and from 26.50±0.61 mmol/L to 3.67±0.29 mmol/L (p<0.0001) in normal and STZ diabetic rats, respectively, after seven days of treatment. Moreover, no significant changes in body weight in normal and STZ rats were shown. According to the lipid profile, the plasma triglycerides levels were decreased significantly in diabetic rats after seven days of ARG treatment (p<0.05). Moreover, seven days of ARG A treatment decreased significantly the plasma cholesterol concentrations (p<0.001). Conclusion: ARG A possesses glucose and lipid-lowering activity in diabetic rats and this natural compound may be beneficial in the treatment of diabetes.

Download Full-text

Pharmaceutical hit of anti type 2 Diabetes mellitus on the phenolic extract of Malaka (Phyllanthus emblica L.) flesh

Clinical Phytoscience ◽

10.1186/s40816-019-0138-7 ◽

2019 ◽

Vol 5 (1) ◽

Author(s):

Musri Musman ◽

Mauli Zakia ◽

Ratu Fazlia Inda Rahmayani ◽

Erlidawati Erlidawati ◽

Safrida Safrida

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Body Weight ◽

Blood Glucose ◽

Phyllanthus Emblica ◽

Glucose Levels ◽

Blood Glucose Levels ◽

Phenolic Extract

Abstract Background Ethnobotany knowledge in a community has shaped local wisdom in utilizing plants to treat diseases, such as the use of Malaka (Phyllanthus emblica) flesh to treat type 2 diabetes. This study presented evidence that the phenolic extract of the Malaka flesh could reduce blood sugar levels in the diabetic induced rats. Methods The phenolic extract of the P. emblica was administrated to the glucose-induced rats of the Wistar strain Rattus norvegicus for 14 days of treatment where the Metformin was used as a positive control. The data generated were analyzed by the two-way ANOVA Software related to the blood glucose level and by SAS Software related to the histopathological studies at a significant 95% confidence. Results The phenolic extract with concentrations of 100 and 200 mg/kg body weight could reduce blood glucose levels in diabetic rats. The post hoc Dunnet test showed that the administration of the extract to the rats with a concentration of 100 mg/kg body weight demonstrated a very significant decrease in blood glucose levels and repaired damaged cells better than administering the extract at a concentration of 200 mg/kg weight body. Conclusion The evidence indicated that the phenolic extract of the Malaka flesh can be utilized as anti type 2 Diabetes mellitus without damaging other organs.

Download Full-text

Influence of Lactobacillus brevis 15 and Lactobacillus plantarum 13 on blood glucose and body weight in rats after high-fructose diet

Beneficial Microbes ◽

10.3920/bm2014.0012 ◽

2015 ◽

Vol 6 (4) ◽

pp. 505-512 ◽

Cited By ~ 11

Author(s):

M. Yakovlieva ◽

T. Tacheva ◽

S. Mihaylova ◽

R. Tropcheva ◽

K. Trifonova ◽

...

Keyword(s):

Body Weight ◽

Lactic Acid ◽

Blood Glucose ◽

Lactic Acid Bacteria ◽

Lactobacillus Plantarum ◽

Lactobacillus Brevis ◽

Control Group ◽

Standard Diet ◽

Glucose Levels ◽

Blood Glucose Levels

In recent years, many authors have investigated the possible antidiabetic effect of lactic acid bacteria. Lactobacillus species constitute a major part of the lactic acid bacteria group and have been found to exhibit beneficial effects on the development of diabetes and its complications. In the current study, we investigated the effects of newly characterised Bulgarian Lactobacillus strains, Lactobacillus brevis 15 and Lactobacillus plantarum 13, on blood glucose levels and body weight of rats fed a fructose-enriched diet. An experiment was conducted over a period of 8 weeks with 24 2-month-old Wistar rats randomly assigned to receive a standard diet (Con, control group), fructose-enriched diet (Fr group), standard diet with probiotics given twice a week (Pro group), and fructose-enriched diet with probiotics given twice a week (Pro+Fr group). At the end of the experimental period, a statistically significant increase in body weight was observed in all experimental groups (P<0.0001). The highest rise was seen in the fructose group (Fr, 169±19 g), followed by the Pro+Fr group (153±15 g), Pro group (149±13 g), and Con group (141±5 g). Moreover, the final blood glucose levels had risen significantly in the groups receiving fructose either without (Fr; P<0.0001) or with lactobacilli (Pro+Fr; P=0.002), while the rise was insignificant in the group of rats given probiotic supplementation only (Pro, P=0.071) and inexistent in the Con group (P=0.999). The highest elevation of blood glucose levels was observed in the Fr group (3.18 mmol/l), followed by the Pro+Fr group (2.00 mmol/l) whereas the Pro group showed the lowest levels (0.60 mmol/l). The results of our study suggest that the newly characterised Bulgarian Lactobacillus strains, L. brevis 15 and L. plantarum 13, could be considered as possible probiotics and might be able to prevent some metabolic disturbances.

Download Full-text

Evaluation of the Effect of Macronutrients Combination on Blood Sugar Levels in Healthy Individuals

Iranian Journal of Public Health ◽

10.18502/ijph.v50i2.5340 ◽

2021 ◽

Author(s):

Berrak BASTURK ◽

Zeynep KOC OZERSON ◽

Aysun YUKSEL

Keyword(s):

Blood Glucose ◽

Fasting Blood Glucose ◽

Protein Source ◽

Carbohydrate Source ◽

Glucose Levels ◽

Positive Effects ◽

Blood Glucose Levels ◽

Before And After ◽

Sugar Levels ◽

Mean Blood Glucose

Background: The positive effects of blood glucose levels should be demonstrated in healthy or type 2 diabetic individuals who can be recommended to consume macronutrients (protein + fat) with carbohydrates. Therefore, at the end of the research planned with the amount of carbohydrates and fats that can be consumed in a meal, we aimed to recommend the consumption of food with high protein content egg together with the carbohydrate source. Methods: The study was carried out from Nov 2017 to Apr 2018 by looking at fasting blood glucose levels using feeding 2 different test foods on a minimum of 8 h of fasting in the Haliç University Sutluce Campus, Istanbul, Turkey. Before and after the carbohydrate and carbohydrate + protein source, blood glucose was measured from the fingertip for 3 days in 30 min, 60 min and 120 min periods. The average of 3 days was used in the analysis. Results: Blood glucose values were compared after individuals were given carbohydrate and carbohydrate + protein source. The mean blood glucose value 60 min after the carbohydrate administration was significantly higher than the average blood glucose value 60 min after the carbohydrate + protein administration (P= 0.006). Conclusion: A protein-containing diet positively affects the glycemia response and can recommend it. In individuals with diabetes, they should focus on the effects of proteins to achieve glycemia control.

Download Full-text

HYPOGLYCEMIC ACTIVITY OF A NOVEL POLYHERBAL FORMULATION IN STREPTOZOTOCIN-INDUCED DIABETIC RATS: A THERAPEUTIC STUDY

Asian Journal of Pharmaceutical and Clinical Research ◽

10.22159/ajpcr.2019.v12i3.29969 ◽

2019 ◽

pp. 218-223

Author(s):

PULAK MAJUMDER ◽

PARIDHAVI M

Keyword(s):

Body Weight ◽

Blood Glucose ◽

Beta Cells ◽

Density Lipoprotein ◽

Diabetic Rats ◽

Glucose Levels ◽

Polyherbal Formulation ◽

Blood Glucose Levels ◽

Therapeutic Study ◽

Glutamyl Transferase

Objective: The concept of the synergistic effect of poly-herbalism was as old as medicine history. Present novel polyherbal formulation (PHF) composed of five different herbs. The present investigation aimed to evaluate the synergistic therapeutic hypoglycemic potential of PHF against streptozotocin (STZ) (60 mg/kg b.w, ip)-induced diabetic rats. Methods: For this therapeutic study, the dose was framed orally once a day to the test objects after STZ dosing at 500 mg/kg/5 ml dosage levels for 21 days. The transformation of body weight and blood glucose level was examined, and the histopathological changes of beta cells of the pancreas, cellular architectures of liver and kidney were also perceived after scarification of the objects. Results: The outcomes were compared to that of glibenclamide (5 mg/kg) treated group. Declines of body weight and blood glucose levels were perceived in STZ-induced diabetic animals very significantly (p<0.01 or p<0.05). However, these diabetic changes were significantly (p<0.01 or p<0.05) decreased in PHF-dosing groups revealed more encouraging effects compared to that of glibenclamide. In the other hand, various liver function and enzymes test (creatinine, urea, total bilirubin, total albumin, alkaline phosphatase, gamma-glutamyl transferase, aspartate transaminases, and alanine transaminases) and lipid profile (total cholesterol, triglycerides, high-density lipoprotein cholesterol, total protein, low-density lipoprotein [LDL], and very LDL) studies strongly indicate the potential action of this novel formulation. Conclusions: It is deliberated that PHF has the favorable effect to normalize the blood glucose levels, and also rejuvenation and reproduction of beta cells lead a better futuristic ant diabetic therapy for diabetic management.

Download Full-text